Cystatin C Assay Market Poised to Reach Over US$ 1.2 Billion by 2034, Driven by Advances in ...
The cystatin C assay market is set for significant expansion as the global healthcare landscape shifts toward early detection ...
Finance News Network2 天
PYC Therapeutics advances kidney disease drug to human trials
Nov 2024 - PYC Therapeutics (ASX:PYC) has announced plans to advance its investigational drug candidate, PYC-003, into human ...